Bullish option flow detected in UroGen Pharma (URGN) with 2,119 calls trading, 1.0x expected, and implied vol increasing over 1 point to 73.67%. Jul-25 7.5 calls and Jul-25 15 calls are the most active options, with total volume in those strikes near 1,300 contracts. The Put/Call Ratio is 0.02. Earnings are expected on August 13th.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on URGN:
- UroGen Pharma’s Promising Outlook: Buy Rating Backed by Clinical Success and FDA Approvals
- UroGen Pharma completes enrollment in Phase 3 UTOPIA trial of UGN-103
- UroGen Pharma Approves Bonuses After FDA Approval
- Sweetgreen, Urogen, CoreWeave, Allegro, Dexcom: Trending by Analysts
- Largest borrow rate increases among liquid names